These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2825943)

  • 21. Specific atrial natriuretic factor receptors mediate increased cyclic GMP accumulation in cultured bovine aortic endothelial and smooth muscle cells.
    Leitman DC; Waldman SA; Rapoport RM; Murad F
    Trans Assoc Am Physicians; 1985; 98():243-52. PubMed ID: 3022442
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscle.
    Winquist RJ; Napier MA; Vandlen RL; Arcuri K; Keegan ME; Faison EP; Baskin EP
    Clin Exp Hypertens A; 1985; 7(5-6):869-86. PubMed ID: 2990774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular atrial natriuretic factor receptors in spontaneously hypertensive rats.
    Schiffrin EL; Parent A; St Louis J; Tremblay J; Garcia R; Thibault G
    Cardiovasc Res; 1992 Sep; 26(9):857-64. PubMed ID: 1360334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
    Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
    J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic cleavage of atrial natriuretic factor receptor in bovine adrenal membranes by endogenous metalloendopeptidase. Effects on guanylate cyclase activity and ligand-binding specificity.
    Abe T; Misono KS
    Eur J Biochem; 1992 Oct; 209(2):717-24. PubMed ID: 1358609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently.
    Arnal JF; el Amrani AI; Michel JB
    Eur J Pharmacol; 1993 Jun; 237(2-3):265-73. PubMed ID: 8396039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of action of atrial natriuretic factor: clinical consequences.
    Gerzer R; Weil J; Strom T; Müller T
    Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic factor in spontaneously hypertensive rats: concentration changes with the progression of hypertension and elevated formation of cyclic GMP.
    Takayanagi R; Imada T; Grammer RT; Misono KS; Naruse M; Inagami T
    J Hypertens Suppl; 1986 Oct; 4(3):S303-7. PubMed ID: 2878070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of atrial natriuretic factor receptors and cyclic GMP response in rabbit renal glomeruli.
    Castro R; Leake RD; Ervin MG; Ross MG; Fisher DA
    Pediatr Res; 1991 Jul; 30(1):45-9. PubMed ID: 1653934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
    Arnal JF; Hofmann F; Michel JB
    Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial natriuretic factor activates membrane-bound guanylate cyclase of chief cells.
    Cherner JA; Singh G; Naik L
    Life Sci; 1990; 47(7):669-77. PubMed ID: 1976196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiloride enhances atrial natriuretic factor stimulation of cGMP accumulation in rat glomeruli.
    Iwata T; Hardee E; Frohlich ED; Cole FE
    Peptides; 1989; 10(3):575-9. PubMed ID: 2571140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II and atrial natriuretic factor receptor interactions at the blood-brain barrier.
    Grammas P; Giacomelli F; Bessert D; Wiener J
    Brain Res; 1991 Oct; 562(1):93-7. PubMed ID: 1686850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competitive peptide antagonists of ANF-induced cyclic guanosine monophosphate production.
    Abell TJ; Richards AM; Yandle TG; Espiner EA; Frampton C; Ikram H
    Biochem Biophys Res Commun; 1989 Oct; 164(1):108-13. PubMed ID: 2553010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
    Ijioma SC; Challiss RA; Boyle JP
    Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular mechanisms of action of atrial natriuretic factor.
    Gerzer R; Heim JM; Schütte B; Weil J
    Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
    Winquist RJ; Faison EP; Waldman SA; Schwartz K; Murad F; Rapoport RM
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7661-4. PubMed ID: 6150486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct atrial natriuretic factor receptor sites on cultured bovine aortic smooth muscle and endothelial cells.
    Schenk DB; Johnson LK; Schwartz K; Sista H; Scarborough RM; Lewicki JA
    Biochem Biophys Res Commun; 1985 Mar; 127(2):433-42. PubMed ID: 2983720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
    Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
    J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.